NovaSom is a privately held diagnostic-service provider for home testing and evaluation of sleep-disordered breathing, including obstructive sleep apnea (OSA).
As an innovator and pioneer in our field, we developed the first FDA-cleared device designed for unattended, unassisted patient use for the diagnosis of sleep apnea, with clinically proven equivalence * to conventional polysomnography (PSG).
*Claman, Murr and Trotter Study
*Reichert, Bloch, Cundiff, and Votteri Study
NovaSom works with private insurers, government and public health organizations to address concerns about the large numbers of individuals with undiagnosed sleep apnea. It is our shared concern that millions of Americans are utilizing more health care resources and incurring greater health care costs because their OSA has not been properly diagnosed or treated.
It is also our belief that early diagnosis and treatment of OSA can improve lives and help hold down health care costs.
Our mission is to improve the health care and quality of life of those impacted by sleep disorders through innovative diagnostic services and by promoting adherence to prescribed therapies.
